Tci Wealth Advisors, Inc. Horizon Therapeutics Public LTD CO Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$62.39 - $113.8 $6,738 - $12,290	108 Added 130.12%	191 $21,000
Q3 2022 Nov 08, 2022	BUY	$58.92 - $84.67 $294 - $423	5 Added 6.41%	83 $5,000
Q2 2022 Jul 19, 2022	SELL	$79.4 - $116.36 $4,843 - $7,097	-61 Reduced 43.88%	78 $6,000
Q1 2022 Apr 29, 2022	SELL	$86.42 - $109.81 $8,037 - $10,212	-93 Reduced 40.09%	139 $14,000
Q3 2021 Oct 29, 2021	BUY	$91.91 - $110.37 $7,628 - $9,160	83 Added 55.7%	232 $25,000
Q2 2021 Aug 02, 2021	BUY	$86.24 - $95.92 $1,638 - $1,822	19 Added 14.62%	149 $14,000
Q1 2021 Apr 29, 2021	BUY	$71.83 - $95.48 $3,735 - $4,964	52 Added 66.67%	130 $12,000
Q1 2020 Apr 14, 2020	BUY	$24.87 - $38.56 $1,939 - $3,007	78 New	78 $2,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.